Cargando…
Feasibility of Recombinant Human TSH as a Preparation for Radioiodine Therapy in Patients with Distant Metastases from Papillary Thyroid Cancer: Comparison of Long-Term Survival Outcomes with Thyroid Hormone Withdrawal
Background: this study was designed to compare the long-term survival outcomes of patients prepared for radioiodine (RAI) therapy using either thyroid hormone withdrawal (THW) or recombinant human thyrotropin (rhTSH) stimulation, by specifically focusing on cases with distant metastases from papilla...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8775305/ https://www.ncbi.nlm.nih.gov/pubmed/35054388 http://dx.doi.org/10.3390/diagnostics12010221 |
_version_ | 1784636550917652480 |
---|---|
author | Tsai, Hsi-Chen Ho, Kung-Chu Chen, Shih-Hsin Tseng, Jing-Ren Yang, Lan-Yan Lin, Kun-Ju Cheng, Ju-Chin Liou, Miaw-Jene |
author_facet | Tsai, Hsi-Chen Ho, Kung-Chu Chen, Shih-Hsin Tseng, Jing-Ren Yang, Lan-Yan Lin, Kun-Ju Cheng, Ju-Chin Liou, Miaw-Jene |
author_sort | Tsai, Hsi-Chen |
collection | PubMed |
description | Background: this study was designed to compare the long-term survival outcomes of patients prepared for radioiodine (RAI) therapy using either thyroid hormone withdrawal (THW) or recombinant human thyrotropin (rhTSH) stimulation, by specifically focusing on cases with distant metastases from papillary thyroid cancer (PTC). Methods: A retrospective analysis was performed on 88 patients with distant metastases from PTC. Fifty-one and thirty-seven patients were prepared for RAI treatment by either THW or rhTSH stimulation, respectively. The primary endpoints were progression-free survival (PFS) and disease-specific survival (DSS). Results: The 10-year DSS rates of patients prepared for RAI therapy using either THW or rhTSH stimulation were 62.2% and 73.3%, respectively. Using multivariate analysis, RAI-avid metastases (p = 0.025) and preparation with rhTSH (p = 0.041) were identified as independent prognostic factors for PFS. Notably, PFS in the group of patients with RAI-avid metastases and preparation with rhTSH was significantly better than that in the other groups (p = 0.025). Conclusions: Preparation for RAI therapy using rhTSH stimulation is not inferior to THW preparation in terms of long-term survival outcomes experienced by patients with PTC and distant metastasis. Patients with RAI-avid metastases and preparation with rhTSH had the most favorable PFS. |
format | Online Article Text |
id | pubmed-8775305 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-87753052022-01-21 Feasibility of Recombinant Human TSH as a Preparation for Radioiodine Therapy in Patients with Distant Metastases from Papillary Thyroid Cancer: Comparison of Long-Term Survival Outcomes with Thyroid Hormone Withdrawal Tsai, Hsi-Chen Ho, Kung-Chu Chen, Shih-Hsin Tseng, Jing-Ren Yang, Lan-Yan Lin, Kun-Ju Cheng, Ju-Chin Liou, Miaw-Jene Diagnostics (Basel) Article Background: this study was designed to compare the long-term survival outcomes of patients prepared for radioiodine (RAI) therapy using either thyroid hormone withdrawal (THW) or recombinant human thyrotropin (rhTSH) stimulation, by specifically focusing on cases with distant metastases from papillary thyroid cancer (PTC). Methods: A retrospective analysis was performed on 88 patients with distant metastases from PTC. Fifty-one and thirty-seven patients were prepared for RAI treatment by either THW or rhTSH stimulation, respectively. The primary endpoints were progression-free survival (PFS) and disease-specific survival (DSS). Results: The 10-year DSS rates of patients prepared for RAI therapy using either THW or rhTSH stimulation were 62.2% and 73.3%, respectively. Using multivariate analysis, RAI-avid metastases (p = 0.025) and preparation with rhTSH (p = 0.041) were identified as independent prognostic factors for PFS. Notably, PFS in the group of patients with RAI-avid metastases and preparation with rhTSH was significantly better than that in the other groups (p = 0.025). Conclusions: Preparation for RAI therapy using rhTSH stimulation is not inferior to THW preparation in terms of long-term survival outcomes experienced by patients with PTC and distant metastasis. Patients with RAI-avid metastases and preparation with rhTSH had the most favorable PFS. MDPI 2022-01-17 /pmc/articles/PMC8775305/ /pubmed/35054388 http://dx.doi.org/10.3390/diagnostics12010221 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Tsai, Hsi-Chen Ho, Kung-Chu Chen, Shih-Hsin Tseng, Jing-Ren Yang, Lan-Yan Lin, Kun-Ju Cheng, Ju-Chin Liou, Miaw-Jene Feasibility of Recombinant Human TSH as a Preparation for Radioiodine Therapy in Patients with Distant Metastases from Papillary Thyroid Cancer: Comparison of Long-Term Survival Outcomes with Thyroid Hormone Withdrawal |
title | Feasibility of Recombinant Human TSH as a Preparation for Radioiodine Therapy in Patients with Distant Metastases from Papillary Thyroid Cancer: Comparison of Long-Term Survival Outcomes with Thyroid Hormone Withdrawal |
title_full | Feasibility of Recombinant Human TSH as a Preparation for Radioiodine Therapy in Patients with Distant Metastases from Papillary Thyroid Cancer: Comparison of Long-Term Survival Outcomes with Thyroid Hormone Withdrawal |
title_fullStr | Feasibility of Recombinant Human TSH as a Preparation for Radioiodine Therapy in Patients with Distant Metastases from Papillary Thyroid Cancer: Comparison of Long-Term Survival Outcomes with Thyroid Hormone Withdrawal |
title_full_unstemmed | Feasibility of Recombinant Human TSH as a Preparation for Radioiodine Therapy in Patients with Distant Metastases from Papillary Thyroid Cancer: Comparison of Long-Term Survival Outcomes with Thyroid Hormone Withdrawal |
title_short | Feasibility of Recombinant Human TSH as a Preparation for Radioiodine Therapy in Patients with Distant Metastases from Papillary Thyroid Cancer: Comparison of Long-Term Survival Outcomes with Thyroid Hormone Withdrawal |
title_sort | feasibility of recombinant human tsh as a preparation for radioiodine therapy in patients with distant metastases from papillary thyroid cancer: comparison of long-term survival outcomes with thyroid hormone withdrawal |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8775305/ https://www.ncbi.nlm.nih.gov/pubmed/35054388 http://dx.doi.org/10.3390/diagnostics12010221 |
work_keys_str_mv | AT tsaihsichen feasibilityofrecombinanthumantshasapreparationforradioiodinetherapyinpatientswithdistantmetastasesfrompapillarythyroidcancercomparisonoflongtermsurvivaloutcomeswiththyroidhormonewithdrawal AT hokungchu feasibilityofrecombinanthumantshasapreparationforradioiodinetherapyinpatientswithdistantmetastasesfrompapillarythyroidcancercomparisonoflongtermsurvivaloutcomeswiththyroidhormonewithdrawal AT chenshihhsin feasibilityofrecombinanthumantshasapreparationforradioiodinetherapyinpatientswithdistantmetastasesfrompapillarythyroidcancercomparisonoflongtermsurvivaloutcomeswiththyroidhormonewithdrawal AT tsengjingren feasibilityofrecombinanthumantshasapreparationforradioiodinetherapyinpatientswithdistantmetastasesfrompapillarythyroidcancercomparisonoflongtermsurvivaloutcomeswiththyroidhormonewithdrawal AT yanglanyan feasibilityofrecombinanthumantshasapreparationforradioiodinetherapyinpatientswithdistantmetastasesfrompapillarythyroidcancercomparisonoflongtermsurvivaloutcomeswiththyroidhormonewithdrawal AT linkunju feasibilityofrecombinanthumantshasapreparationforradioiodinetherapyinpatientswithdistantmetastasesfrompapillarythyroidcancercomparisonoflongtermsurvivaloutcomeswiththyroidhormonewithdrawal AT chengjuchin feasibilityofrecombinanthumantshasapreparationforradioiodinetherapyinpatientswithdistantmetastasesfrompapillarythyroidcancercomparisonoflongtermsurvivaloutcomeswiththyroidhormonewithdrawal AT lioumiawjene feasibilityofrecombinanthumantshasapreparationforradioiodinetherapyinpatientswithdistantmetastasesfrompapillarythyroidcancercomparisonoflongtermsurvivaloutcomeswiththyroidhormonewithdrawal |